Daejeon, South Korea

Seung Woong Lee

This inventor holds 2 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seung Woong Lee. Retrieved from https://idiyas.com/inventor/seung-woong-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 8.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Seung Woong Lee in Renal Toxicity and Immunity Enhancement

Introduction

Seung Woong Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the fields of pharmacology and biotechnology, particularly in the development of compositions aimed at preventing renal toxicity and enhancing immunity. With a total of two patents to his name, his work reflects a commitment to advancing medical science and improving patient outcomes.

Latest Patents

One of Seung Woong Lee's latest patents is a composition comprising oleanolic acid acetate as an active ingredient for preventing, alleviating, or treating renal toxicity induced by medicine. This invention focuses on a pharmaceutical composition that utilizes oleanolic acid acetate or its pharmaceutically acceptable salts to combat drug-induced nephrotoxicity, especially from platinum-based anticancer drugs. The composition is derived from natural products, ensuring it has no side effects or cytotoxicity, making it a promising candidate for pharmaceutical applications.

Another notable patent involves a composition for enhancing immunity, which contains compounds represented by specific chemical formulas or extracts from sophora flavescens. This invention aims to induce the expression of interferon-β, thereby preventing, alleviating, or treating diseases that can be managed by increasing interferon levels. The versatility of this composition allows it to be used in various forms, including feed additives, pharmaceutical compositions, and over-the-counter drugs.

Career Highlights

Seung Woong Lee is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research and development activities. His work is characterized by a strong focus on innovative solutions to pressing health issues, particularly in the realm of drug safety and immune response enhancement.

Collaborations

Seung Woong Lee collaborates with notable colleagues, including Mun Chual Rho and Woo Song Lee. These partnerships enhance the research capabilities and broaden the impact of their collective work in the scientific community.

Conclusion

Seung Woong Lee's contributions to the fields of renal toxicity prevention and immunity enhancement showcase his innovative spirit and dedication to improving health outcomes. His patents reflect a deep understanding of pharmacological principles and a commitment to harnessing natural compounds for therapeutic use.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…